Literature DB >> 7061868

Influence of molecular size of IgA on its immunoassay by various techniques. II. Solid-phase radioimmunoassays.

D L Delacroix, J P Dehennin, J P Vaerman.   

Abstract

Homogeneous, polymeric (P), monoclonal (MC) and polyclonal (PC) samples of purified IgA, as well as of secretory IgA (sIgA), were compared to their corresponding monomeric (M) forms with regard to their respective behaviour in both a solid-phase double antibody (AB) immunoradiometric assay (IRMA) and a solid-phase competition radioimmunoassay (CRIA). On an identical weight basis, both assays underestimated the P forms. Correction factors (CF), i.e., optical density (OD) versus radiometric concentration ratios, were calculated for both methods for all P forms, using M as standards. IRMA CF were respectively 1.50 for dimer, 1.98 for secretory IgA and 2.40 for tetramers, very similar to those obtained in radial immunodiffusion (RID). With optimally coated beads, these CF were stable along a wide range of concentrations. In contrast, CRIA-CF were 3-4 times larger and displayed much variation along their standard range of concentrations, preventing the use of a constant CF along the standard curve. Our present IRMA, with its CF, should be of value for a more accurate quantitation of small amounts of IgA of various known sizes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7061868     DOI: 10.1016/0022-1759(82)90333-7

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  22 in total

1.  Lack of SC/pIgR-mediated epithelial transport of a human polymeric IgA devoid of J chain: in vitro and in vivo studies.

Authors:  J P Vaerman; A Langendries; D Giffroy; P Brandtzaeg; K Kobayashi
Journal:  Immunology       Date:  1998-09       Impact factor: 7.397

2.  Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women.

Authors:  P A Kozlowski; S Cu-Uvin; M R Neutra; T P Flanigan
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

3.  Prolonged and preferential production of polymeric immunoglobulin A in response to Streptococcus pneumoniae capsular polysaccharides.

Authors:  S Johnson; N L Opstad; J M Douglas; E N Janoff
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

4.  Immunoglobulins in nasal secretions of healthy humans: structural integrity of secretory immunoglobulin A1 (IgA1) and occurrence of neutralizing antibodies to IgA1 proteases of nasal bacteria.

Authors:  L Kirkeby; T T Rasmussen; J Reinholdt; M Kilian
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

5.  Immunoglobulin A concentrations in commercial immune globulins.

Authors:  R Apfelzweig; D Piszkiewicz; J A Hooper
Journal:  J Clin Immunol       Date:  1987-01       Impact factor: 8.317

6.  A rapid, convenient enzyme linked immunosorbent assay for total immunoglobulin A in serum.

Authors:  M C Booth; J P Gosling; P F Fottrell; C F McCarthy
Journal:  Ir J Med Sci       Date:  1985-04       Impact factor: 1.568

7.  Gall bladder: the predominant source of bile IgA in man?

Authors:  D A Vuitton; E Seilles; P Claude; P Sava; D L Delacroix
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

8.  Kinetics of anti-Campylobacter jejuni monomeric and polymeric immunoglobulin A1 and A2 responses in serum during acute enteritis.

Authors:  F O Mascart-Lemone; J R Duchateau; J Oosterom; J P Butzler; D L Delacroix
Journal:  J Clin Microbiol       Date:  1987-07       Impact factor: 5.948

9.  Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection.

Authors:  M Warny; J P Vaerman; V Avesani; M Delmée
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

10.  Selective transport of polymeric immunoglobulin A in bile. Quantitative relationships of monomeric and polymeric immunoglobulin A, immunoglobulin M, and other proteins in serum, bile, and saliva.

Authors:  D L Delacroix; H J Hodgson; A McPherson; C Dive; J P Vaerman
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.